Anti-vascular endothelial growth factor therapy in polypoidal choroidal vasculopathy. [PDF]
Giridhar A, Lekha T, Chandran K.
europepmc +1 more source
Intravitreal Brolucizumab Use for Retinal Vascular Diseases in Resource-Constrained Settings: A Retrospective Study From Bangladesh. [PDF]
Moniruzzaman M +5 more
europepmc +1 more source
Real-world efficacy and safety of Brolucizumab injection in vitrectomised eyes (BIVE) - a prospective multicentric study. [PDF]
Boral SK +4 more
europepmc +1 more source
Signals of drug-related retinal artery occlusion: a multi-country retrospective study from a spontaneous reporting system. [PDF]
Cao X, Zeng J, Wu S, Wu C, Zhou X, Ou Y.
europepmc +1 more source
From bench to bed: The evolution of anti-vascular endothelial growth factor therapies. [PDF]
Sen A, Kohli G, Agarwal A, Chauhan R.
europepmc +1 more source
Molecular Determinants of Intravitreal Anti-VEGF Durability: Drug Architecture, Intraocular Pharmacokinetics, Target Biology and Treatment Resistance. [PDF]
Panos GD +8 more
europepmc +1 more source
Use of Aflibercept 8 mg for the Treatment of Diabetic Macular Edema in Italy: A Cost-Minimisation Analysis Based on an Indirect Treatment Comparison. [PDF]
Cortesi PA +6 more
europepmc +1 more source
Special Issue "Molecular Application of Mass Spectrometry and Chromatography in Biomedicine". [PDF]
Ventura G, Bianco M.
europepmc +1 more source
Quantitative Optical Coherence Tomography Angiography Biomarkers Following a Switch to Brolucizumab in Neovascular Age-Related Macular Degeneration. [PDF]
Lee S, Choi J, Yu SY, Kim K.
europepmc +1 more source

